1. Home
  2. CDIO

as of 12-19-2025 2:05pm EST

$2.98
+$0.16
+5.52%
Stocks Health Care Biotechnology: Commercial Physical & Biological Resarch Nasdaq

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Chart Type:
Time Range:
Founded: 2017 Country:
United States
United States
Employees: N/A City: CHICAGO
Market Cap: 5.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 23.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -4.03 EPS Growth: N/A
52 Week Low/High: $2.42 - $39.30 Next Earning Date: 11-12-2025
Revenue: $15,782 Revenue Growth: -55.78%
Revenue Growth (this year): 1434.82% Revenue Growth (next year): 4661.90%

Share on Social Networks: